Skip to main content
. 2014 Nov 5;290(1):184–196. doi: 10.1074/jbc.M114.587030

TABLE 1.

Oligonucleotides used in InsP3R3–3′-UTR constructs and in the mutagenesis of miR-506 binding sites

Oligo name Sequence 5′ → 3′
InsP3R3–3′-UTR Fa ATGCTCATCACTGGAGACTGCG
InsP3R3–3′-UTR AGGGGCTCTTGTTCCTGTCTTCTG
3′-UTR PWF CGCGTCACTGGGACTCAGTTTACCTTAAT
GCCTTAGCAGAAGATAAATCCTAAGA
3′-UTR PWR AGCTTTTCTAGGAGGATTTATCTTCTGC
TAAGGCATTAAGGTAAACTGAGTCCCAGTG
3′-UTR PMF CGCGTCACTGGGACTCAGTTTACCTTAATG
AAGTAGCAGAAGATAAATCCTAAGA
3′-UTR PMR AGCTTTCTTAGGATTTATCTTCTGCTA[i]CTTC
ATTAAGGTAAACTGAGTCCCAGTG
3′-UTR DWF CGCGTCAAATCCTTTGGCCTGAGAACTAAT
ATGTTAATTGCCTTAAATAAATTAATAGAAATCTAGTCCGTTAAAAA
3′-UTR DWR AGCTTTTTTTAACGGACTAGATTTCTATTAA
TTTATTTAAGGCAATTAACATATTAGTTCTCAGGCCAAAGGATTTG
3′-UTR DMF CGCGTCAAATCCTTTGGCCTGAGAACTAAT
ATGTTAATTG[i]AAGTAAATAAATTAATAGAAATCTAGTCCGTTAAAAA
3′-UTR DMR AGCTTTTTTTTAACGGACTAGATTTCTATTA
ATTTATTTA[i]CTTCAATTAACATATTAGTTCTCAGGCCAAAGGATTG

a The following abbreviations are used: F, forward; R, reverse; PW and PM, proximal wild-type and mutant miR-506 binding site; DW and DM, distal wild-type and mutant miR-506 binding site. Mutated bases are in italics and underlined.